CSL Manufactures Virus Vaccine
CSL Manufactures Virus Vaccine
CSL to produce AstraZeneca Vaccine in Melbourne
CSL is confident it can make an updated version of AstraZeneca’s COVID-19 vaccine to cover any virus variants that might arise – putting the ball in the medical regulator’s court for a quick approval.
The Australian pharma giant is preparing to begin the process of bottling the first doses of the life-saving vaccine in the coming days.
The federal government has contracted CSL to make 50 million doses of AstraZeneca’s two-dose vaccine. The first batch is set for harvest on Monday at the company’s Parkville campus before a six-week process of testing and filling the vaccine into vials.
A vaccination campaign is expected to begin in March, the federal government has said. CSL hopes to make more than one million doses a week when at full production at their cell culture facility at Broadmeadows.
Photo from The Age - Jason South
Friday, 12 February 2021